f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "12a5855b-2b0a-4e51-a9c3-c0790d093c30", | | "id": "12a5855b-2b0a-4e51-a9c3-c0790d093c30", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:12:01.654347", | | "metadata_created": "2021-09-16T08:12:01.654347", |
n | "metadata_modified": "2022-04-27T13:34:04.653920", | n | "metadata_modified": "2022-04-27T13:36:01.574703", |
| "name": "malawi-integrated-hiv-program-report-2015-q2", | | "name": "malawi-integrated-hiv-program-report-2015-q2", |
| "notes": "A summary of the key achievements between April and June | | "notes": "A summary of the key achievements between April and June |
| 2015 is provided below:\r\n\r\n* Scale-up of integrated HIV services | | 2015 is provided below:\r\n\r\n* Scale-up of integrated HIV services |
| had reached the following number of sites:\r\n\r\n * __724__ static | | had reached the following number of sites:\r\n\r\n * __724__ static |
| (579 within and 145 outside of health facilities) and 188 outreach HTC | | (579 within and 145 outside of health facilities) and 188 outreach HTC |
t | sites\r\n\r\n * __711__ (static) ART sites\r\n\r\n * __601__ | t | sites\r\n\r\n * __711__ (static) ART sites\r\n\r\n * __601__ |
| PMTCT sites (Option B+, all included in ART sites above)\r\n\r\n * | | PMTCT sites (Option B+, all included in ART sites above)\r\n\r\n * |
| __662__ Pre-ART sites\r\n\r\n * __642__ sites with HIV-exposed child | | __662__ Pre-ART sites\r\n\r\n * __642__ sites with HIV-exposed |
| follow-up\r\n\r\n* __493,567__ persons were tested and counselled for | | child follow-up\r\n\r\n* __493,567__ persons were tested and |
| HIV; __150,728 (31%)__ accessed HTC for the first time;\r\n__342,839 | | counselled for HIV; __150,728 (31%)__ accessed HTC for the first |
| (69%)__ were repeat testers and __9,820 (3%)__ of these received | | time;\r\n__342,839 (69%)__ were repeat testers and __9,820 (3%)__ of |
| confirmatory testing (after\r\nhaving tested positive in the past). | | these received confirmatory testing (after\r\nhaving tested positive |
| This is equivalent to 35% confirmatory testing coverage | | in the past). This is equivalent to 35% confirmatory testing coverage |
| among\r\n__25,957__ patients initiating ART this quarter. __29,285 | | among\r\n__25,957__ patients initiating ART this quarter. __29,285 |
| (6%)__ clients received a positive result for the | | (6%)__ clients received a positive result for the |
| first\r\ntime.\r\n\r\n* __19,596 (95%)__ of __20,538__ blood units | | first\r\ntime.\r\n\r\n* __19,596 (95%)__ of __20,538__ blood units |
| collected were screened for (at least) HIV, hepatitis B | | collected were screened for (at least) HIV, hepatitis B |
| and\r\nsyphilis.\r\n\r\n* __141,212 (91%)__ of __155,272__ women at | | and\r\nsyphilis.\r\n\r\n* __141,212 (91%)__ of __155,272__ women at |
| ANC had their HIV status ascertained; __10,766 (8%)__ of these\r\nwere | | ANC had their HIV status ascertained; __10,766 (8%)__ of these\r\nwere |
| HIV positive. __120,781 (96%)__ of 1__25,961__ women at maternity had | | HIV positive. __120,781 (96%)__ of 1__25,961__ women at maternity had |
| their HIV status ascertained\r\n__8,967 (7%)__ of these were HIV | | their HIV status ascertained\r\n__8,967 (7%)__ of these were HIV |
| positive.\r\n\r\n* __25,957__ patients started ART this | | positive.\r\n\r\n* __25,957__ patients started ART this |
| quarter.\r\n\r\n* __568,470__ patients were alive and on ART by end of | | quarter.\r\n\r\n* __568,470__ patients were alive and on ART by end of |
| June 2015. This means that 57% of the estimated\r\n1 million HIV | | June 2015. This means that 57% of the estimated\r\n1 million HIV |
| positive population was on ART. 1 Estimated ART coverage among people | | positive population was on ART. 1 Estimated ART coverage among people |
| in need for\r\ntreatment1 was 49% (49,407 / 101,000) for children (<15 | | in need for\r\ntreatment1 was 49% (49,407 / 101,000) for children (<15 |
| years) and 67% (519,063 / 779,000) for\r\nadults.\r\n\r\n* __79%__ of | | years) and 67% (519,063 / 779,000) for\r\nadults.\r\n\r\n* __79%__ of |
| adults and __78%__ of children were retained alive on ART at 12 months | | adults and __78%__ of children were retained alive on ART at 12 months |
| after initiation. Actual\r\nretention rates are thought to be about | | after initiation. Actual\r\nretention rates are thought to be about |
| 10% higher due to misclassification of \u2018silent transfers\u2019 | | 10% higher due to misclassification of \u2018silent transfers\u2019 |
| as\r\ndefaulters in clinic-based survival/retention analysis. (see | | as\r\ndefaulters in clinic-based survival/retention analysis. (see |
| section 16.4)\r\n\r\n* __493,034 (93%)__ of __531,106__ patients on | | section 16.4)\r\n\r\n* __493,034 (93%)__ of __531,106__ patients on |
| first line adult ART were on regimen 5A (TDF/3TC/EFV).\r\n\r\n* | | first line adult ART were on regimen 5A (TDF/3TC/EFV).\r\n\r\n* |
| __10,460 (70%)__ of an estimated __14,926__ HIV infected pregnant | | __10,460 (70%)__ of an estimated __14,926__ HIV infected pregnant |
| women in Malawi were on ART this\r\nquarter. __5,960 (57%)__ of these | | women in Malawi were on ART this\r\nquarter. __5,960 (57%)__ of these |
| were already on ART when getting pregnant and __4,500 (43%)__ | | were already on ART when getting pregnant and __4,500 (43%)__ |
| started\r\nART during pregnancy/delivery.\r\n* An additional __1,591__ | | started\r\nART during pregnancy/delivery.\r\n* An additional __1,591__ |
| breastfeeding women started ART due to Option B+ (in WHO stage | | breastfeeding women started ART due to Option B+ (in WHO stage |
| 1/2)\r\n\r\n* __76%__, __72%__, __67%__ and __69%__ of women started | | 1/2)\r\n\r\n* __76%__, __72%__, __67%__ and __69%__ of women started |
| under Option B+ were retained on ART at 6, 12, 24 and 36 months after | | under Option B+ were retained on ART at 6, 12, 24 and 36 months after |
| initiation, respectively.\r\n\r\n* __8,210 (7%)__ of infants | | initiation, respectively.\r\n\r\n* __8,210 (7%)__ of infants |
| discharged alive from maternity were known to be HIV exposed, __7,771 | | discharged alive from maternity were known to be HIV exposed, __7,771 |
| (95%)__\r\nof these received ARV prophylaxis (nevirapine). __6,563 | | (95%)__\r\nof these received ARV prophylaxis (nevirapine). __6,563 |
| (80%)__were enrolled in exposed child followup\r\nbefore age 2 | | (80%)__were enrolled in exposed child followup\r\nbefore age 2 |
| months.\r\n* A total of __10,396__ HIV exposed children and __6,077__ | | months.\r\n* A total of __10,396__ HIV exposed children and __6,077__ |
| pre-ART patients were enrolled for follow-up in\r\nHIV Care Clinics | | pre-ART patients were enrolled for follow-up in\r\nHIV Care Clinics |
| (HCC) during this quarter.", | | (HCC) during this quarter.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:56:26.879796", | | "created": "2022-03-23T19:56:26.879796", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "15dcb014-e679-4c8b-a86b-9515ea9841dc", | | "id": "15dcb014-e679-4c8b-a86b-9515ea9841dc", |
| "last_modified": "2022-04-04T23:40:13.693058", | | "last_modified": "2022-04-04T23:40:13.693058", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2015-q2", | | "dha/malawi-integrated-hiv-program-report-2015-q2", |
| "metadata_modified": "2022-04-04T23:40:13.708310", | | "metadata_modified": "2022-04-04T23:40:13.708310", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2015-q2", | | "name": "malawi-integrated-hiv-program-report-2015-q2", |
| "package_id": "12a5855b-2b0a-4e51-a9c3-c0790d093c30", | | "package_id": "12a5855b-2b0a-4e51-a9c3-c0790d093c30", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "ac9a610a6d90c04b723552bb11ab381ef166ada9a9ab839cb661ae07277b7054", | | "ac9a610a6d90c04b723552bb11ab381ef166ada9a9ab839cb661ae07277b7054", |
| "size": 2161301, | | "size": 2161301, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 15ea9841dc/download/malawi-integrated-hiv-program-report-2015-q2.pdf", | | 15ea9841dc/download/malawi-integrated-hiv-program-report-2015-q2.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2015 Q2", | | "title": "Malawi Integrated HIV Program Report 2015 Q2", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2015" | | "year": "2015" |
| } | | } |